Imagenología
¹H Magnetic Resonance Spectroscopy demonstrates different metabolic features in Gliomatosis Cerebri
References
1.- Nevin S. Gliomatosis cerebri. Brain 1938; 61: 170-191
2.-Yang S, Wetzel S and Cha S. Dynamic Contrast-Enhanced T2*-Weighted MR Imaging of Gliomatosis Cerebri. Am J Neuroradiol 2002; 23: 350-355.
3.-Bendszus M, Warmuth-Metz, Klein R, Burger R, Schichor C, Tonn J and Solymosi L. MR Spectroscopy in Gliomatosis Cerebri. Am J Neuroradiol 2000; 21: 375-380.
4.-Lin A, Ross B, Harris K and Wong W. Efficacy of Proton Magnetic Resonance Spectroscopy in Neurological Diagnosis and Neurotherapeutic Decision Making. NeuroRx. 2005; 2: 197–214.
5.- Pyhtinen J. Proton MR spectroscopy in gliomatosis cerebri. Neuroradiology 2000; 42: 612-615.
6.-Saraf-Lavi E, Bowen B, Pattany P, Sklar E, Murdoch J and Petito C. Proton MR Spectroscopy of Gliomatosis Cerebri: Case Report of Elevated Myoinositol with Normal Choline Levels. Am J Neuroradiol 2003; 24: 946-951.
7.-Mohana-Borges A, Imbesi S, Dietrich R, Alksne J, Amjadi D and Darius K. Role of Proton Magnetic Resonance Spectroscopy in the Diagnosis of Gliomatosis Cerebri: A Unique Pattern of Normal Choline but Elevated Myo-Inositol Metabolite Levels. J Comput Assist Tomogr. 2004; 28: 103-105.
8.-Castillo M, Smith J and Kwock L. Correlation of Myo-inositol Levels and Grading of Cerebral Astrocytomas. Am J Neuroradiol 2000;21:1645-1649.
9.-Londoño A, Castillo M, Armao D, Kwock L, Suzuki K. Unusual MR spectroscopic imaging pattern of an astrocytoma: lack of elevated choline and high myo-inositol and glycine levels. Am J Neuroradiol. 2003;24(5):942-5
10.-Panigrahy A, Krieger M, Gonzalez-Gomez I, Liu X, McComb J, Finlay J, Nelson M, Gilles F and Blüml S. Quantitative Short Echo Time 1H-MR Spectroscopy of Untreated Pediatric Brain Tumors: Preoperative Diagnosis and Characterization. Am J Neuroradiol 2006; 27:560-572.
11.-Hattingen E , Raab P , Franz K , Zanella F, Lanfermann H and Pilatus U. Myo-Inositol: a marker of reactive astrogliosis in glial tumors? NMR in Biomedicine 2007; 21: 233 – 241.
12.- Panigrahy A, Nelson M, Finlay J, Sposto R, Krieger M, Gilles F and Blüml S. Metabolism of diffuse intrinsic brainstem gliomas in children. Neuro Oncol 2008; 10:32-44.
13.- Imamura K. Proton MR Spectroscopy of the Brain with a Focus on Chemical Issues. Magn Res Med Sci 2003; 2: 117-132.
14.- Galanaud D, Chinot O, Nicoli F, Confort-Gouny S, Le Fur Y, Barrie-Attarian M, Ranjeva J, Fuentès S, Viout P, Figarella-Branger D and Cozzone P. Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. J Neurosurg 2003; 98: 269-276.
15.- Kararizou E, Likomanos D, Gkiatas K, Markou I, Triantafyllou N, Kararizos G. Magnetic resonance spectroscopy: a noninvasive diagnosis of gliomatosis cerebri. Magn Reson Imag 2006;24: 205-207.
16.-Uysal E, Erturk M, Yildirim H, Karatag O, Can M, Tanik C and Basak M. Multivoxel Magnetic Resonance Spectroscopy in Gliomatosis Cerebri. Acta Radiol. 2005;46:621-624.
|
